Iridex Eye Disease Treatment Fails in Study
685976
Iridex Corp.  on Friday said its  experimental laser treatment for the leading cause of  age-related blindness was no better than a placebo in a  clinical trial, sending shares down 6 percent.
281554
A U.S. advisory panel on Friday will  review data on an experimental drug that is injected into the  eye to stop vision loss in elderly patients at risk of going  blind.
438872
By Sabine Vollmer, The News & Observer, Raleigh, N.C.  Feb. 17--Adding a treatment for pink eye to its lineup of promising medicines could cost Inspire Pharmaceuticals $32 million in upfront and milestone payments.
151431
An experimental drug developed by Eyetech Pharmaceuticals Inc. and Pfizer Inc. for preserving vision in the elderly received a generally positive review from a US advisory panel on Friday.
94632
WASHINGTON -- A drug that attacks a major cause of blindness passed a key hurdle Friday as the government&#39;s scientific advisers decided that it poses no significant risks.
207035
AstraZeneca Plc has withdrawn its  marketing application for lung cancer pill Iressa in Europe  after the drug failed to help patients live longer in a  clinical study, Europe's third largest drugmaker said on  Tuesday.
463333
AstraZeneca faced its third major setback in as many months yesterday after clinical trials dashed expectations that its lung cancer drug Iressa would develop into a blockbuster product that would dominate treatment around the world.
736402
Patients with type 2 diabetes and hypertension who kept their blood pressure very tightly controlled had fewer eye disorders caused by their diabetes, according to an article in the November issue of The Archives of Ophthalmology, one of the JAMA/Archives
402091
Eyetech (EYET:Nasdaq - news - research) did not open for trading Friday because a Food and Drug Administration advisory committee is meeting to review the small New York-based biotech&#39;s experimental eye disease drug.
438184
NEW YORK  - Despite being at increased risk   for illness and death, renal disease patients are frequently   excluded from randomized trials looking at treatments for   cardiovascular disease (CVD), according to a report released   this week.
301160
Transplants of insulin-making cells have not lived up to the promise they showed in an initial trial.
268759
The larger pharmaceutical drops out of daclizumab development.
122409
An experimental drug developed by Eyetech Pharmaceuticals Inc. and Pfizer Inc. for preserving vision in the elderly received a generally positive review from a U.S. advisory panel on Friday.
357965
Monthly eye injections of the drug Lucentis can dramatically improve sight in people with the "wet" form of macular degeneration, the leading cause of blindness in the elderly, two studies showed on Wednesday.
83518
Merck & Co and Schering-Plough Corp said a closely watched study involving its Vytorin cholesterol treatment failed to reach its main goal.
278954
Shares of Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) fell Monday even though several analysts said the company&#39;s experimental eye disease drug Macugen has a good chance of securing government approval.
260309
The outcome of a clinical trial that failed to show that Zetia has any medical benefits adds to concerns over the popular drug.